APA (7th ed.) Citation

J, M., R, K., M, S., C, S., F, W., E, S., . . . R, G. (2025). CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies. The Lancet. Neurology, 24(7), 564. https://doi.org/10.1016/S1474-4422(25)00199-1

Chicago Style (17th ed.) Citation

J, Motte, et al. "CD19-targeted CAR T-cell Therapy for Treatment-refractory Autoimmune Neuropathies." The Lancet. Neurology 24, no. 7 (2025): 564. https://doi.org/10.1016/S1474-4422(25)00199-1.

MLA (9th ed.) Citation

J, Motte, et al. "CD19-targeted CAR T-cell Therapy for Treatment-refractory Autoimmune Neuropathies." The Lancet. Neurology, vol. 24, no. 7, 2025, p. 564, https://doi.org/10.1016/S1474-4422(25)00199-1.